from UBS issued a price target of $148.00 for C on 2026-10-14 13:18:00.The adjusted price target was set to $148.00.At the time of the announcement, C was trading at $122.745.The overall price target consensus is at $151.15 with high price of $165.00, low price of $135.00, and median price is at $151.00.C currently trades -16.31%...
from UBS issued a price target of $148.00 for C on 2026-10-14 13:18:00.The adjusted price target...
Phillip Jungwirth from BMO Capital issued a price target of $68.00 for OXY on 2026-10-14 13:06:00.The...
from RBC Capital issued a price target of $280.00 for JNJ on 2026-10-14 12:57:58.The adjusted price...
Gerard Cassidy from RBC Capital issued a price target of $135.00 for C on 2026-10-14 12:52:00.The...
from UBS issued a price target of $148.00 for C on 2026-10-14 13:18:00.The adjusted price target was set to $148.00.At the time of the announcement, C was trading at $122.745.The...
from UBS issued a price target of $148.00 for C on 2026-10-14 13:18:00.The adjusted price target was set to $148.00.At the time of the announcement, C was trading at $122.745.The...
Phillip Jungwirth from BMO Capital issued a price target of $68.00 for OXY on 2026-10-14 13:06:00.The adjusted price target was set to $68.00.At the time of the announcement, OXY was...
from RBC Capital issued a price target of $280.00 for JNJ on 2026-10-14 12:57:58.The adjusted price target was set to $280.00.At the time of the announcement, JNJ was trading at...
Gerard Cassidy from RBC Capital issued a price target of $135.00 for C on 2026-10-14 12:52:00.The adjusted price target was set to $135.00.At the time of the announcement, C was...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In a significant move to bolster its green energy initiatives, American Electric Power (AEP) has announced plans to invest $4 billion in a new fuel cell project aimed at powering...
For the past two years, Nvidia has established itself as the leading player in the artificial intelligence (AI) chip market, captivating the industry's attention with its high-performance Graphics Processing Units...
NVIDIA's CEO Jensen Huang recently stated that AI tokens have transitioned into productive and profitable assets, a transformation that the tech giant is leveraging to generate substantial revenue. As NVIDIA...
Microsoft (NASDAQ: MSFT), the blue-chip technology titan, appears ready to resume its previous upward trajectory following a dip in early 2026. Analysts' notes from October 12 indicate a robust outlook...
Recent legislative efforts to address soaring energy bills in California are paving the way for significant benefits for major players in the energy and technology sectors, including Tesla, Sunrun, Enphase,...
